Corrections to Peptide Pros USA
An error in the population, formulation or outcome can change the whole argument.
Source corrections
Editorial mailbox: editors@peptideprosusa.com
A useful note identifies the page and passage, then gives the paper title, DOI or PubMed identifier that supports the correction. A correction to a misplaced compound name would be particularly useful: tesamorelin and sermorelin, or DAC and no-DAC, are easy to compress into an unjustified comparison. A new controlled result on the fixed combination would also deserve close attention.
The reading list collects the sources already used here. A correction needs enough information to be checked against that record.
Requests about treatment
The mailbox cannot assess symptoms, interpret personal tests, arrange care or supply a dose or schedule. It also cannot locate peptide suppliers. Individual treatment questions require a licensed clinician’s assessment; editorial replies are not a substitute for that care. Replies to research correspondence are not guaranteed.